Sandra Baldwin

Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

Sandra Baldwin, J. C. Bloomer, Graeme Smith et al. · Xenobiotica · 1995 · 298 citations

Medicine, Biochemistry, Pharmacology +17

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor

Aili L. Lazaar, Lucy Yang, Rebecca Boardley et al. · British Journal of Clinical Pharmacology · 2015 · 178 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7

Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes

Stephen E. Clarke, Sandra Baldwin, J. C. Bloomer et al. · Chemical Research in Toxicology · 1994 · 59 citations

Medicine, Biochemistry, Pharmacology +14

CYTOCHROME P450 GENE INDUCTION IN RATS EX VIVO ASSESSED BY QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (TAQMAN)

Sandra Baldwin, Jo L. Bramhall, Charlotte Ashby et al. · Drug Metabolism and Disposition · 2006 · 53 citations

Medicine, Pharmacology, Toxicology +16

The Extent and Impact of Variation in ADME Genes in Sub-Saharan African Populations

Jorge da Rocha, Houcemeddine Othman, Gerrit Botha et al. · Frontiers in Pharmacology · 2021 · 34 citations · Full text

Medicine, Genetics, Molecular Genetics +9